Carlyle Investment Management L.L.C.
https://www.carlyle.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Carlyle Investment Management L.L.C.
AstraZeneca’s LogicBio Buyout Will Give Other Troubled Gene Therapy Companies Hope
Many gene therapies companies have faced R&D and financial problems this year but the longer term potential of the field and low prices might tempt big pharma into deals.
Bigger Money: Private Equity Grabs European VC
Deals show large investors’ appetite for early-stage biotech, but can VC and PE rub along?
Shape Scores Big Pharma Dollars In Roche Deal For AI-Driven AAV Technology
Shape Therapeutics is the latest start-up to attract big bucks from big pharma for novel AAV technology that could address some of the safety concerns around gene therapy.
Inhaler Manufacturer Board Approves Takeover By Tobacco Company
The board members of Vectura, a manufacturer of inhalers and inhaled drugs, have approved a $1.4bn takeover bid by Philip Morris International, the manufacturer of Marlboro cigarettes.
Company Information
- Industry
- Miscellaneous
- Pharmaceuticals
- Services
-
Services
- Managed Care, Insurance, Integrated Systems
- Other Names / Subsidiaries
-
- Albany Molecular Research, Inc. (AMRI)
- Cedarburg Pharmaceuticals, Inc.
- Excelsyn Ltd.
- Hyaluron Inc.
- Gadea Pharmaceutical Group (Crystal Pharma)
- Ortho-Clinical Diagnostics, Inc.
- Ortho Diagnostic Systems, Inc.
- Prime European Therapeuticals S.p.A. (Euticals)
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice